Drug application
ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL (ERYTHROMYCIN ETHYLSUCCINATE, SULFISOXAZOLE ACETYL)
Drugs@FDA ANDA 062759 · BARR
Key facts
| Drug name | ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL |
|---|---|
| Active ingredients | ERYTHROMYCIN ETHYLSUCCINATE, SULFISOXAZOLE ACETYL |
| Application type | ANDA |
| Application number | 062759 |
| Company | BARR |
| Dosage forms | GRANULE, ORAL |
| Strength | EQ 200MG BASE/5ML;EQ 600MG BASE/5ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | May 20, 1988 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.